Ilsung IS
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Ilsung IS is a health-care company listed on KOSPI, South Korea's main stock exchange, operating in the pharmaceuticals or related health-care space.
The filing does not provide sufficient detail to describe its specific products, end-customers, or supply-chain position with confidence. The company is currently profitable, though its revenue has declined on a year-over-year basis.
Summary is AI-generated and may contain errors · figures from DART filings
Ilsung IS in five facts
What does Ilsung IS do?
Ilsung IS is a health-care company listed on KOSPI, South Korea's main stock exchange, operating in the pharmaceuticals or related health-care space.
Where is Ilsung IS listed and in which sector?
Ilsung IS (Korean name: 일성아이에스) trades under KRX code 003120 on KOSPI, the main board of the Korea Exchange. It is classified in the Health Care sector, Pharmaceuticals.
How large is Ilsung IS?
Its market capitalisation was US$219.8M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Ilsung IS's latest annual revenue and operating profit?
For fiscal year 2025, Ilsung IS reported revenue of US$48.5M, an operating loss of US$4.6M and net income of US$879.9K, per its annual report on DART (data retrieved from DART on 2026-09-06). Revenue was down 6.8% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-06
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- DisclosureSep 30
- Share cancellation decisionSep 30
- Cash/in-kind dividend decision
Ilsung IS declared a cash dividend of US$0.83 per share.
Dividend · Feb 25 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Ilsung IS reported separate results for FY2025: revenue of US$44.3M (−6.85% year on year), an operating loss of US$4.24M and net income of US$935K (−89.63% year on year).
Earnings · Feb 3